Skip to content
Menu

RBC Capital Maintains Outperform on Privia Health Gr, Raises Price Target to $32

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

RBC Capital analyst Ryan Halsted maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $31 to $32.

RBC Capital analyst Ryan Halsted maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $31 to $32.

Read at benzinga.com